Capillary Technologies India Limited has completed the allotment of 64,680 equity shares under its Employee Stock Option Scheme 2021 (ESOP Plan 2021), as announced in a regulatory filing dated April 17, 2026. The allotment represents the exercise of vested stock options by employees under the company's share-based compensation program.

Share Allotment Details

The Nomination and Remuneration Committee of the Board of Directors approved the allotment through a circular resolution on April 16, 2026. The shares were issued in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Impact on Share Capital

Following this ESOP allotment, the company's equity structure has been updated with significant changes to the total issued shares and share capital.

Regulatory Compliance

The company has fulfilled all regulatory requirements under the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The statement under Regulation 10(b) for ESOP Plan 2021 was previously filed with both BSE Limited and National Stock Exchange of India Limited on January 08, 2026, with filing numbers 256643 and 52926 respectively.

Share Characteristics

The newly allotted equity shares are identical in all respects to the existing equity shares of the company and rank pari passu with them. No lock-in provisions apply to these shares, and no listing fees are associated with this allotment. The shares are listed on both the National Stock Exchange of India Limited and BSE Limited under the symbol CAPILLARY and scrip code 544614 respectively.

This ESOP allotment reflects the company's ongoing commitment to employee participation in its equity growth and aligns with standard corporate practices for retaining and incentivizing key personnel through share-based compensation schemes.

Capillary technologies India Limited has submitted its mandatory initial disclosure for FY 2025-26 to both BSE and NSE, fulfilling regulatory requirements under multiple SEBI circulars. The disclosure provides key financial and compliance information as of March 31, 2026.

Financial Position and Borrowings

The company reported outstanding borrowings of ₹44.72 crore as of March 31, 2026. This disclosure was made pursuant to SEBI circular requirements that mandate companies to provide initial disclosures at the beginning of each financial year.

Regulatory Compliance Framework

The submission was made in accordance with several SEBI circulars, including SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and subsequent amendments. The company specifically confirmed that it does not qualify as a 'Large Corporate' under the SEBI framework criteria.

Key compliance aspects covered in the disclosure include:

• Outstanding borrowing position as of the financial year-end
• Credit rating status during the previous financial year
• Classification under the Large Corporate framework
• Stock exchange fine payment obligations, if applicable

Corporate Structure and Leadership

The disclosure was formally submitted on April 16, 2026, with digital signatures from key executives. Company Secretary and Compliance Officer Gireddy Bhargavi Reddy (Membership No. A17091) and Chief Financial Officer Anant Choubey both signed the document from the company's Bengaluru office.

Company Information

Capillary Technologies India Limited operates under CIN L72200KA2012PLC063060 with its registered office located in HSR Layout, Bengaluru, Karnataka. The company maintains its corporate website at www.capillarytech.com and can be contacted at secretarial@capillarytech.com for investor relations matters.

The submission to both major Indian stock exchanges ensures compliance with listing requirements and provides transparency to stakeholders regarding the company's financial position and regulatory status for the current financial year.